[
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b001",
    "text": "Date of Approval Letter: June 2, 2006",
    "bbox": [
      208.3,
      84.7,
      425.1,
      100.2
    ],
    "font_size": 14.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b002",
    "text": "FREEDOM OF INFORMATION SUMMARY",
    "bbox": [
      115.1,
      173.3,
      538.3,
      197.7
    ],
    "font_size": 22.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "H1"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b003",
    "text": "SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION",
    "bbox": [
      119.5,
      228.3,
      515.0,
      246.0
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b004",
    "text": "NADA 140-338",
    "bbox": [
      263.3,
      288.7,
      371.2,
      306.4
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b005",
    "text": "NAXCEL Sterile Powder",
    "bbox": [
      233.0,
      349.1,
      404.9,
      366.8
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b006",
    "text": "(ceftiofur sodium)",
    "bbox": [
      256.4,
      367.5,
      377.6,
      385.2
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b007",
    "text": "To establish a 4-day pre-slaughter withdrawal period for cattle",
    "bbox": [
      140.1,
      437.9,
      493.4,
      453.4
    ],
    "font_size": 14.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b008",
    "text": "Sponsored by:",
    "bbox": [
      268.8,
      484.6,
      365.1,
      502.3
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b009",
    "text": "Pharmacia & Upjohn Co.,",
    "bbox": [
      231.4,
      503.0,
      406.6,
      520.7
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 1,
    "block_id": "980_p1_b010",
    "text": "a Division of Pfizer, Inc.",
    "bbox": [
      235.6,
      521.4,
      398.4,
      539.1
    ],
    "font_size": 16.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b001",
    "text": "GENERAL INFORMATION:",
    "bbox": [
      108.0,
      72.6,
      260.4,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "H4"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b002",
    "text": "a. File Number:",
    "bbox": [
      108.0,
      96.5,
      193.2,
      109.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b003",
    "text": "NADA 140-338",
    "bbox": [
      287.9,
      96.5,
      368.6,
      109.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b004",
    "text": "b. Sponsor:",
    "bbox": [
      108.0,
      120.5,
      171.7,
      133.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b005",
    "text": "Pharmacia & Upjohn Co.",
    "bbox": [
      288.0,
      120.5,
      413.0,
      133.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b006",
    "text": "a Division of Pfizer, Inc.",
    "bbox": [
      288.0,
      134.5,
      409.7,
      147.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b007",
    "text": "235 East 42d St.",
    "bbox": [
      288.0,
      148.5,
      369.7,
      161.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b008",
    "text": "New York, NY  10017",
    "bbox": [
      288.0,
      162.5,
      400.5,
      175.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b009",
    "text": "Drug Labeler Code:  000009",
    "bbox": [
      288.0,
      186.5,
      429.1,
      199.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b010",
    "text": "c. Established Name:",
    "bbox": [
      108.0,
      210.5,
      219.4,
      223.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b011",
    "text": "Ceftiofur sodium",
    "bbox": [
      288.0,
      210.5,
      373.3,
      223.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b012",
    "text": "d. Proprietary Name:",
    "bbox": [
      108.0,
      234.5,
      217.9,
      247.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b013",
    "text": "NAXCEL Sterile Powder",
    "bbox": [
      287.9,
      234.5,
      413.0,
      247.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b014",
    "text": "e. Dosage Form:",
    "bbox": [
      108.0,
      258.5,
      197.4,
      271.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b015",
    "text": "Sterile powder for reconstitution to injectable",
    "bbox": [
      288.1,
      258.5,
      509.8,
      271.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b016",
    "text": "solution",
    "bbox": [
      288.0,
      272.4,
      329.8,
      285.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b017",
    "text": "f. How Supplied:",
    "bbox": [
      108.0,
      296.4,
      201.4,
      309.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b018",
    "text": "1 and 4 g glass vial",
    "bbox": [
      288.1,
      296.4,
      383.4,
      309.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b019",
    "text": "g. How Dispensed:",
    "bbox": [
      108.0,
      320.4,
      208.6,
      333.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b020",
    "text": "h. Amount of Active Ingredients:",
    "bbox": [
      108.0,
      344.4,
      276.7,
      357.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b021",
    "text": "50 mg ceftiofur equivalents (CE) per mL of",
    "bbox": [
      288.0,
      344.4,
      500.6,
      357.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b022",
    "text": "reconstituted solution",
    "bbox": [
      288.0,
      358.4,
      394.9,
      371.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b023",
    "text": "i. Route of Administration:",
    "bbox": [
      108.0,
      382.4,
      252.8,
      395.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b024",
    "text": "Intramuscular (IM) or subcutaneous (SC) injection",
    "bbox": [
      288.1,
      382.4,
      535.0,
      395.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b025",
    "text": "j. Species/Class:",
    "bbox": [
      108.0,
      406.4,
      198.5,
      419.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b026",
    "text": "Cattle; may be used in lactating dairy cattle",
    "bbox": [
      288.0,
      406.4,
      499.7,
      419.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b027",
    "text": "k. Recommended Dosage:",
    "bbox": [
      108.0,
      430.4,
      246.2,
      443.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b028",
    "text": "0.5 to 1.0 mg ceftiofur per pound of body weight",
    "bbox": [
      288.0,
      430.4,
      526.0,
      443.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b029",
    "text": "(1-2 mL reconstituted sterile solution per 100 lb",
    "bbox": [
      288.0,
      444.4,
      521.7,
      457.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b030",
    "text": "body weight).  Treatment should be repeated at 24-",
    "bbox": [
      288.0,
      458.4,
      533.8,
      471.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b031",
    "text": "hour intervals for a total of three consecutive days.",
    "bbox": [
      288.0,
      472.4,
      538.1,
      485.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b032",
    "text": "Additional treatments may be given on days four",
    "bbox": [
      288.0,
      486.3,
      526.1,
      499.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b033",
    "text": "and five for animals which do not show a",
    "bbox": [
      288.0,
      500.3,
      489.7,
      513.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b034",
    "text": "satisfactory response (not recovered) after the initial",
    "bbox": [
      288.0,
      514.3,
      542.2,
      527.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b035",
    "text": "three treatments.",
    "bbox": [
      288.0,
      528.3,
      371.1,
      541.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b036",
    "text": "l. Pharmacological Category:",
    "bbox": [
      108.0,
      552.3,
      263.1,
      565.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b037",
    "text": "Antimicrobial",
    "bbox": [
      288.0,
      552.3,
      358.4,
      565.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b038",
    "text": "m. Indications:",
    "bbox": [
      108.0,
      576.3,
      185.8,
      589.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b039",
    "text": "NAXCEL Sterile Powder is indicated for treatment",
    "bbox": [
      288.0,
      576.3,
      537.2,
      589.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b040",
    "text": "of bovine respiratory disease (shipping fever,",
    "bbox": [
      288.0,
      590.3,
      508.6,
      603.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b041",
    "text": "pneumonia) associated with Mannheimia",
    "bbox": [
      288.0,
      604.2,
      488.8,
      617.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b042",
    "text": "haemolytica, Pasteurella multocida, and",
    "bbox": [
      288.0,
      618.2,
      485.6,
      631.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b043",
    "text": "Histophilus somni.  NAXCEL Sterile Powder is",
    "bbox": [
      288.0,
      632.2,
      520.8,
      645.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b044",
    "text": "also indicated for treatment of acute bovine",
    "bbox": [
      288.0,
      646.2,
      499.9,
      659.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b045",
    "text": "interdigital necrobacillosis (foot rot,",
    "bbox": [
      288.0,
      660.2,
      464.8,
      673.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b046",
    "text": "pododermatitis) associated with Fusobacterium",
    "bbox": [
      288.0,
      674.1,
      519.6,
      687.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 2,
    "block_id": "980_p2_b047",
    "text": "necrophorum and Bacteroides melaninogenicus.",
    "bbox": [
      288.0,
      688.1,
      523.9,
      701.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b001",
    "text": "n. Effect of Supplement:",
    "bbox": [
      108.0,
      72.6,
      235.0,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b002",
    "text": "To establish a 4-day pre-slaughter withdrawal",
    "bbox": [
      288.1,
      72.6,
      511.7,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b003",
    "text": "period for cattle",
    "bbox": [
      288.0,
      86.6,
      367.8,
      99.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b004",
    "text": "2. EFFECTIVENESS:",
    "bbox": [
      90.0,
      124.6,
      212.8,
      137.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH1"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b005",
    "text": "CVM did not require effectiveness studies for this supplemental approval.  The FOI",
    "bbox": [
      108.0,
      152.5,
      513.7,
      165.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b006",
    "text": "Summaries for the original approval of NAXCEL Sterile Powder (NADA 140-338) dated",
    "bbox": [
      108.0,
      166.5,
      541.3,
      179.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b007",
    "text": "January 25, 1988, and the supplemental approvals of NADA 140-338 dated April 5,",
    "bbox": [
      108.0,
      180.5,
      514.2,
      193.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b008",
    "text": "1990; August 24, 1995; and May 29, 2001, contain summaries of studies that",
    "bbox": [
      108.0,
      194.4,
      481.5,
      207.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b009",
    "text": "demonstrate effectiveness of the drug for cattle.",
    "bbox": [
      108.0,
      208.4,
      343.1,
      221.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b010",
    "text": "3. TARGET ANIMAL SAFETY:",
    "bbox": [
      90.0,
      236.5,
      260.8,
      249.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH2"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b011",
    "text": "CVM did not require target animal safety studies for this supplemental approval.  The",
    "bbox": [
      108.0,
      264.2,
      523.4,
      277.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b012",
    "text": "FOI Summaries for the original approval of NAXCEL Sterile Powder (NADA 140-338)",
    "bbox": [
      108.0,
      278.2,
      534.6,
      291.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b013",
    "text": "dated January 25, 1988, and the supplemental approvals of NADA 140-338 dated",
    "bbox": [
      108.0,
      292.2,
      502.8,
      305.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b014",
    "text": "April 5, 1990, and May 29, 2001, contain summaries of target animal safety studies for",
    "bbox": [
      108.0,
      306.2,
      529.2,
      319.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b015",
    "text": "cattle.",
    "bbox": [
      108.0,
      320.1,
      143.1,
      333.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b016",
    "text": "4. HUMAN FOOD SAFETY:",
    "bbox": [
      90.0,
      348.2,
      245.5,
      361.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH2"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b017",
    "text": "A.  Toxicology",
    "bbox": [
      108.0,
      376.2,
      184.7,
      389.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "H4"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b018",
    "text": "The toxicity testing of ceftiofur is summarized in the FOI Summary for the original",
    "bbox": [
      126.0,
      400.1,
      529.4,
      413.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b019",
    "text": "approval of NAXCEL Sterile Powder (NADA 140-338) dated January 25, 1988, and",
    "bbox": [
      126.0,
      414.1,
      536.0,
      427.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b020",
    "text": "in the FOI Summary dated April 1996, for the original approval of EXCENEL RTU",
    "bbox": [
      126.0,
      428.1,
      533.0,
      441.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b021",
    "text": "(ceftiofur hydrochloride) Sterile Suspension (NADA 140-890) for use in swine.",
    "bbox": [
      126.0,
      442.1,
      515.0,
      455.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b022",
    "text": "Tolerances for cattle are summarized in the FOI Summary for NAXCEL XT (now",
    "bbox": [
      126.0,
      456.0,
      524.2,
      469.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b023",
    "text": "EXCEDE) Sterile Suspension (NADA 141-209) dated September 5, 2003.",
    "bbox": [
      126.0,
      470.0,
      486.5,
      483.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b024",
    "text": "Safe concentrations are established for cattle as follows:",
    "bbox": [
      126.0,
      496.0,
      399.0,
      509.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b025",
    "text": "Muscle:",
    "bbox": [
      144.0,
      522.0,
      185.7,
      535.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b026",
    "text": "4.4 ppm",
    "bbox": [
      234.0,
      522.0,
      276.2,
      535.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b027",
    "text": "Liver:",
    "bbox": [
      144.0,
      536.0,
      176.4,
      549.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b028",
    "text": "13.2 ppm",
    "bbox": [
      234.0,
      536.0,
      282.2,
      549.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b029",
    "text": "Kidney:",
    "bbox": [
      144.0,
      549.9,
      188.7,
      563.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b030",
    "text": "26.4 ppm",
    "bbox": [
      234.0,
      549.9,
      282.2,
      563.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b031",
    "text": "Fat:",
    "bbox": [
      144.0,
      563.9,
      165.7,
      577.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b032",
    "text": "26.4 ppm",
    "bbox": [
      234.0,
      563.9,
      282.3,
      577.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b033",
    "text": "Injection site:",
    "bbox": [
      144.0,
      577.9,
      215.8,
      591.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b034",
    "text": "166 ppm",
    "bbox": [
      233.9,
      577.9,
      279.2,
      591.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b035",
    "text": "Milk:",
    "bbox": [
      144.0,
      591.9,
      173.7,
      605.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b036",
    "text": "0.320 ppm",
    "bbox": [
      234.0,
      591.9,
      288.2,
      605.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b037",
    "text": "B.  Residue Chemistry",
    "bbox": [
      108.0,
      618.0,
      225.7,
      631.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "H4"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b038",
    "text": "The total residue depletion and metabolism in the target species and comparative",
    "bbox": [
      126.0,
      641.9,
      517.8,
      655.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b039",
    "text": "metabolism in the toxicological species for ceftiofur are summarized in the FOI",
    "bbox": [
      126.0,
      655.9,
      511.6,
      669.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b040",
    "text": "Summaries under NADA 140-338 and NADA 140-890.  The following pivotal study",
    "bbox": [
      126.0,
      669.9,
      537.5,
      683.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 3,
    "block_id": "980_p3_b041",
    "text": "was conducted to confirm applicable withdrawal periods in cattle.",
    "bbox": [
      126.0,
      683.9,
      445.6,
      697.2
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b001",
    "text": "1. Study",
    "bbox": [
      126.0,
      72.6,
      175.0,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b002",
    "text": "“Decline of ceftiofur and desfuroylceftiofur-related metabolites in bovine tissues",
    "bbox": [
      144.0,
      98.6,
      535.4,
      111.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b003",
    "text": "after intramuscular administration of ceftiofur sodium (NAXCEL Sterile Powder)",
    "bbox": [
      144.0,
      112.5,
      539.8,
      125.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b004",
    "text": "to cattle at a rate of 2.2 mg ceftiofur equivalents/kg body weight for five",
    "bbox": [
      144.0,
      126.5,
      494.6,
      139.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b005",
    "text": "consecutive days”.  Study Number: 2000-0427.  June 2001.",
    "bbox": [
      144.0,
      140.5,
      432.8,
      153.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b006",
    "text": "Principal Investigators:  D.A. Merritt and M.J. Prough, Pfizer Animal Health,",
    "bbox": [
      144.0,
      160.5,
      519.4,
      173.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b007",
    "text": "Kalamazoo, MI",
    "bbox": [
      144.0,
      174.5,
      222.3,
      187.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b008",
    "text": "Animal Species:  Bovine",
    "bbox": [
      144.0,
      194.4,
      269.7,
      207.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b009",
    "text": "Breed:  Mixed breed",
    "bbox": [
      144.0,
      214.4,
      249.1,
      227.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b010",
    "text": "Number of Animals/Sex:  38; 18 male and 18 female (plus 1 male and 1 female",
    "bbox": [
      144.0,
      234.4,
      528.4,
      247.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b011",
    "text": "control animals)",
    "bbox": [
      144.0,
      248.4,
      228.4,
      261.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b012",
    "text": "Weights of Animals:  200 to 297 kg",
    "bbox": [
      144.0,
      268.4,
      322.3,
      281.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b013",
    "text": "Health Status:  Clinically healthy",
    "bbox": [
      144.0,
      288.3,
      309.7,
      301.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b014",
    "text": "Route of Administration:  Intramuscular (IM) injection",
    "bbox": [
      144.0,
      308.3,
      411.3,
      321.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b015",
    "text": "Dose Rate:  2.2 mg ceftiofur equivalents (CE)/kg body weight (actual dose 2.25 ±",
    "bbox": [
      144.0,
      328.3,
      540.2,
      341.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b016",
    "text": "0.03 mg CE/kg BW)",
    "bbox": [
      144.0,
      342.3,
      249.1,
      355.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b017",
    "text": "Duration of Dosing:  one injection daily for five consecutive days",
    "bbox": [
      144.0,
      362.3,
      465.7,
      375.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b018",
    "text": "Marker Residue Depletion Data:  Samples of kidney, liver, injection site, muscle,",
    "bbox": [
      144.0,
      382.2,
      537.7,
      395.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b019",
    "text": "and fat were assayed for desfuroylceftiofur-related residue by the HPLC-DCA",
    "bbox": [
      144.0,
      396.2,
      523.5,
      409.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b020",
    "text": "assay.  The results of the assays are provided in Table 1.  The limit of detection",
    "bbox": [
      144.0,
      410.2,
      528.1,
      423.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b021",
    "text": "(LOD) of the assay was 0.05 ppm and the limit of quantification (LOQ) was",
    "bbox": [
      144.0,
      424.2,
      513.0,
      437.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b022",
    "text": "0.10 ppm.",
    "bbox": [
      144.0,
      438.2,
      195.2,
      451.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b023",
    "text": "Table 1.  Mean Concentration of Ceftiofur and Desfuroylceftiofur-Related Residues",
    "bbox": [
      131.4,
      464.3,
      526.3,
      476.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b024",
    "text": "(as DCA) in Bovine Tissues from Animals Receiving Five Doses of NAXCEL Sterile",
    "bbox": [
      131.4,
      477.2,
      524.9,
      489.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b025",
    "text": "Powder (2.2 mg CE/kg BW)",
    "bbox": [
      131.4,
      490.1,
      265.2,
      502.2
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b026",
    "text": "Mean ± S.D., ppm",
    "bbox": [
      335.5,
      502.7,
      423.2,
      516.2
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b027",
    "text": "Tissue",
    "bbox": [
      138.1,
      516.6,
      170.7,
      528.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b028",
    "text": "3 hours",
    "bbox": [
      193.9,
      523.8,
      231.8,
      536.0
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b029",
    "text": "24 hours",
    "bbox": [
      254.2,
      523.8,
      297.6,
      536.0
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b030",
    "text": "48 hours",
    "bbox": [
      317.1,
      523.8,
      360.6,
      536.0
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b031",
    "text": "72 hours",
    "bbox": [
      380.1,
      523.8,
      423.5,
      536.0
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b032",
    "text": "96 hours",
    "bbox": [
      443.1,
      523.8,
      486.5,
      536.0
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b033",
    "text": "121",
    "bbox": [
      509.2,
      517.4,
      528.5,
      529.5
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b034",
    "text": "hours",
    "bbox": [
      504.1,
      530.3,
      533.7,
      542.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b035",
    "text": "Kidney",
    "bbox": [
      136.7,
      543.8,
      171.9,
      555.9
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b036",
    "text": "5.29 ± 0.79  1.00 ± 0.18",
    "bbox": [
      186.4,
      542.9,
      302.3,
      556.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b037",
    "text": "0.35 ± 0.08",
    "bbox": [
      312.4,
      542.9,
      365.3,
      556.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b038",
    "text": "0.20 ± 0.07",
    "bbox": [
      375.4,
      542.9,
      428.3,
      556.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b039",
    "text": "0.12 ± 0.02",
    "bbox": [
      438.4,
      542.9,
      491.3,
      556.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b040",
    "text": "< LOQ",
    "bbox": [
      501.7,
      543.8,
      536.0,
      555.9
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b041",
    "text": "Injection",
    "bbox": [
      133.4,
      557.4,
      175.3,
      569.6
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b042",
    "text": "site",
    "bbox": [
      145.4,
      570.1,
      163.4,
      582.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b043",
    "text": "33 ± 18",
    "bbox": [
      194.7,
      562.9,
      233.8,
      576.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b044",
    "text": "0.94 ± 0.85",
    "bbox": [
      249.4,
      562.9,
      302.3,
      576.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b045",
    "text": "0.25 ± 0.07",
    "bbox": [
      312.4,
      562.9,
      365.3,
      576.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b046",
    "text": "0.15 ± 0.06",
    "bbox": [
      375.4,
      562.9,
      428.3,
      576.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b047",
    "text": "0.21 ± 0.13",
    "bbox": [
      438.4,
      562.9,
      491.3,
      576.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b048",
    "text": "< LOQ",
    "bbox": [
      501.7,
      563.8,
      536.0,
      575.9
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b049",
    "text": "Liver",
    "bbox": [
      141.1,
      583.7,
      167.6,
      595.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b050",
    "text": "1.60 ± 0.25  0.19 ± 0.06",
    "bbox": [
      186.4,
      582.8,
      302.3,
      596.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b051",
    "text": "0.44 ± 0.13",
    "bbox": [
      312.4,
      582.8,
      365.3,
      596.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b052",
    "text": "< LOQ",
    "bbox": [
      384.7,
      583.7,
      419.0,
      595.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b053",
    "text": "< LOQ",
    "bbox": [
      447.7,
      583.7,
      481.9,
      595.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b054",
    "text": "< LOQ",
    "bbox": [
      501.7,
      583.7,
      535.9,
      595.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b055",
    "text": "Muscle",
    "bbox": [
      136.8,
      597.7,
      171.9,
      609.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b056",
    "text": "0.36 ± 0.04",
    "bbox": [
      186.4,
      596.8,
      242.1,
      610.3
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b057",
    "text": "< LOQ",
    "bbox": [
      258.7,
      597.7,
      293.0,
      609.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b058",
    "text": "< LOD",
    "bbox": [
      321.7,
      597.7,
      355.9,
      609.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b059",
    "text": "< LOD",
    "bbox": [
      384.7,
      597.7,
      418.9,
      609.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b060",
    "text": "<LOD",
    "bbox": [
      449.1,
      597.7,
      480.5,
      609.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b061",
    "text": "Fat",
    "bbox": [
      146.0,
      611.6,
      162.8,
      623.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b062",
    "text": "0.31 ± 0.15",
    "bbox": [
      186.4,
      610.8,
      242.1,
      624.2
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b063",
    "text": "< LOQ",
    "bbox": [
      258.7,
      611.6,
      293.0,
      623.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b064",
    "text": "< LOD",
    "bbox": [
      321.7,
      611.6,
      355.9,
      623.8
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b065",
    "text": "NA = not assayed",
    "bbox": [
      131.4,
      625.3,
      212.7,
      637.4
    ],
    "font_size": 11.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b066",
    "text": "By 3 hours after the last dose, all injection sites contained less than 95 ppm DCA.",
    "bbox": [
      144.0,
      648.1,
      542.8,
      661.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 4,
    "block_id": "980_p4_b067",
    "text": "2. Target Tissue and Marker Residue",
    "bbox": [
      126.0,
      674.1,
      313.2,
      687.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b001",
    "text": "The target tissue for residue monitoring is kidney.  The marker residue in edible",
    "bbox": [
      144.0,
      72.6,
      531.4,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b002",
    "text": "tissues, including milk, is the sum of ceftiofur and desfuroylceftiofur-related",
    "bbox": [
      144.0,
      86.6,
      514.3,
      99.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b003",
    "text": "metabolites, measured by HPLC as the stable derivative desfuroylceftiofur",
    "bbox": [
      144.0,
      100.5,
      505.5,
      113.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b004",
    "text": "acetamide (DCA).",
    "bbox": [
      144.0,
      114.5,
      235.0,
      127.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b005",
    "text": "3. Tolerances",
    "bbox": [
      126.0,
      140.5,
      199.7,
      153.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b006",
    "text": "Cattle tolerances are:  0.4 ppm DCA in kidney, 2 ppm DCA in liver, 1 ppm DCA",
    "bbox": [
      144.0,
      166.5,
      536.5,
      179.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b007",
    "text": "in muscle, and 0.1 ppm DCA in milk.  For research purposes, a value of 95 ppm",
    "bbox": [
      144.0,
      180.5,
      531.5,
      193.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b008",
    "text": "DCA has been established for making decisions regarding the safety of the",
    "bbox": [
      144.0,
      194.4,
      506.2,
      207.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b009",
    "text": "injection site.",
    "bbox": [
      144.0,
      208.4,
      211.9,
      221.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b010",
    "text": "4. Withdrawal Period",
    "bbox": [
      126.0,
      234.4,
      238.0,
      247.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b011",
    "text": "The kidney data were analyzed with a statistical method which determines the",
    "bbox": [
      144.0,
      260.4,
      522.3,
      273.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b012",
    "text": "statistical tolerance limit for the 99th percentile of the population with",
    "bbox": [
      144.0,
      272.4,
      481.1,
      287.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b013",
    "text": "95% confidence as outlined in FDA’s Guideline for Establishing a Withdrawal",
    "bbox": [
      144.0,
      288.3,
      527.5,
      301.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b014",
    "text": "Period.  The tolerance limit falls below the kidney tolerance of 0.4 ppm at 93 hours",
    "bbox": [
      144.0,
      302.3,
      548.3,
      315.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b015",
    "text": "after the last dose.  The data support the assignment of a 96-hour (4-day) pre-",
    "bbox": [
      144.0,
      316.3,
      516.1,
      329.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b016",
    "text": "slaughter withdrawal period for the IM treatment.",
    "bbox": [
      144.0,
      330.3,
      385.6,
      343.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b017",
    "text": "Based on a comparison of residue data for the SC route of administration (FOI",
    "bbox": [
      144.0,
      356.3,
      524.2,
      369.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b018",
    "text": "Summary for NADA 140-338 dated May 29, 2001) vs. that for the IM route, FDA",
    "bbox": [
      144.0,
      370.2,
      541.9,
      383.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b019",
    "text": "also established a 4-day pre-slaughter withdrawal period for the SC treatment.",
    "bbox": [
      144.0,
      384.2,
      522.5,
      397.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b020",
    "text": "5. Milk Discard",
    "bbox": [
      126.0,
      410.2,
      210.8,
      423.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b021",
    "text": "The milk tolerance has not changed.  Consequently, no milk out data were",
    "bbox": [
      144.0,
      436.2,
      503.9,
      449.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b022",
    "text": "required and the no discard can be maintained.",
    "bbox": [
      144.0,
      450.2,
      377.2,
      463.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b023",
    "text": "C.  Microbial Food Safety",
    "bbox": [
      108.0,
      474.3,
      243.4,
      487.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "H4"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b024",
    "text": "FDA concluded the impact of the proposed supplemental application on microbial",
    "bbox": [
      126.0,
      498.2,
      523.9,
      511.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b025",
    "text": "food safety was not of a magnitude that required a hazard characterization or a full",
    "bbox": [
      126.0,
      512.2,
      526.0,
      525.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b026",
    "text": "microbial food safety assessment.",
    "bbox": [
      126.0,
      526.2,
      291.1,
      539.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b027",
    "text": "D.  Analytical Methods for Residues",
    "bbox": [
      108.0,
      552.3,
      295.8,
      565.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldMT",
    "label": "H4"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b028",
    "text": "The regulatory method for determination of DCA in swine kidney and muscle, and",
    "bbox": [
      126.0,
      580.2,
      526.7,
      593.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b029",
    "text": "bovine kidney, muscle, and milk is the HPLC-DCA assay which successfully",
    "bbox": [
      126.0,
      594.2,
      500.4,
      607.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b030",
    "text": "completed a sponsor-monitored multi-laboratory method trial.  The method is on file",
    "bbox": [
      126.0,
      608.1,
      535.8,
      621.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b031",
    "text": "with the Center for Veterinary Medicine, Food and Drug Administration,",
    "bbox": [
      126.0,
      622.1,
      480.3,
      635.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b032",
    "text": "7500 Standish Place, Rockville, MD  20855.",
    "bbox": [
      126.0,
      636.1,
      343.5,
      649.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b033",
    "text": "5. USER SAFETY:",
    "bbox": [
      90.0,
      668.1,
      194.6,
      681.4
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH1"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b034",
    "text": "Studies to evaluate the safety of ceftiofur to users are discussed in detail in the original",
    "bbox": [
      108.0,
      692.0,
      528.0,
      705.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 5,
    "block_id": "980_p5_b035",
    "text": "FOI Summary for NAXCEL Sterile Powder (NADA 140-338) dated January 25, 1988.",
    "bbox": [
      108.0,
      706.0,
      528.5,
      719.3
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b001",
    "text": "Human Warnings are provided on the product labeling as follows:",
    "bbox": [
      108.0,
      72.6,
      431.8,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b002",
    "text": "Not for human use.  Keep out of reach of children.",
    "bbox": [
      108.0,
      96.6,
      359.7,
      109.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b003",
    "text": "Penicillins and cephalosporins can cause allergic reactions in sensitized individuals.",
    "bbox": [
      108.0,
      120.6,
      517.4,
      133.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b004",
    "text": "Topical exposures to such antimicrobials, including ceftiofur, may elicit mild to severe",
    "bbox": [
      108.0,
      134.6,
      528.5,
      147.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b005",
    "text": "allergic reactions in some individuals.  Repeated or prolonged exposure may lead to",
    "bbox": [
      108.0,
      148.5,
      514.4,
      161.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b006",
    "text": "sensitization.  Avoid direct contact of the product with the skin, eyes, mouth and",
    "bbox": [
      108.0,
      162.5,
      498.1,
      175.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b007",
    "text": "clothing.",
    "bbox": [
      108.0,
      176.5,
      159.4,
      189.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b008",
    "text": "Persons with a known hypersensitivity to penicillin or cephalosporins should avoid",
    "bbox": [
      108.0,
      200.5,
      510.3,
      213.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b009",
    "text": "exposure to this product.",
    "bbox": [
      108.0,
      214.5,
      229.9,
      227.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b010",
    "text": "In case of accidental eye exposure, flush with water for 15 minutes.  In case of accidental",
    "bbox": [
      108.0,
      238.5,
      540.0,
      251.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b011",
    "text": "skin exposure, wash with soap and water.  Remove contaminated clothing.",
    "bbox": [
      108.0,
      252.5,
      475.5,
      265.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b012",
    "text": "If allergic reaction occurs (e.g., skin rash, hives, difficult breathing), seek medical",
    "bbox": [
      108.0,
      276.5,
      504.5,
      289.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b013",
    "text": "attention.",
    "bbox": [
      108.0,
      290.4,
      156.1,
      303.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b014",
    "text": "The material safety data sheet contains more detailed occupational safety information.",
    "bbox": [
      108.0,
      318.4,
      528.1,
      331.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b015",
    "text": "To obtain a material safety data sheet (MSDS) please call 1-800-733-5500.  To report",
    "bbox": [
      108.0,
      332.4,
      522.8,
      345.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b016",
    "text": "any adverse event please call 1-800-366-5288.",
    "bbox": [
      108.0,
      346.4,
      334.7,
      359.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b017",
    "text": "6. AGENCY CONCLUSIONS:",
    "bbox": [
      90.0,
      374.4,
      251.1,
      387.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH2"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b018",
    "text": "The data submitted in support of this NADA satisfy the requirements of section 512 of",
    "bbox": [
      108.0,
      398.3,
      527.2,
      411.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b019",
    "text": "the Federal Food, Drug, and Cosmetic Act and 21 CFR Part 514 of the implementing",
    "bbox": [
      108.0,
      412.3,
      519.8,
      425.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b020",
    "text": "regulations.  The data demonstrate that NAXCEL Sterile Powder, when administered",
    "bbox": [
      108.0,
      426.3,
      520.5,
      439.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b021",
    "text": "according to the label directions, is safe and effective for the treatment of bovine",
    "bbox": [
      108.0,
      440.3,
      498.7,
      453.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b022",
    "text": "respiratory disease (shipping fever, pneumonia) associated with Mannheimia",
    "bbox": [
      108.0,
      454.2,
      480.8,
      467.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b023",
    "text": "haemolytica, Pasteurella multocida, and Histophilus somni; and for the treatment of",
    "bbox": [
      108.0,
      468.2,
      515.4,
      481.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b024",
    "text": "acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with",
    "bbox": [
      108.0,
      482.2,
      504.8,
      495.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b025",
    "text": "Fusobacterium necrophorum and Bacteroides melaninogenicus.",
    "bbox": [
      108.0,
      496.2,
      419.6,
      509.5
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b026",
    "text": "Labeling restricts this drug to use by or on the order of a licensed veterinarian.  This",
    "bbox": [
      108.0,
      519.3,
      515.3,
      532.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b027",
    "text": "decision was based on the following factors:  (a) adequate directions cannot be written to",
    "bbox": [
      108.0,
      532.4,
      538.9,
      545.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b028",
    "text": "enable lay persons to appropriately diagnose and subsequently use this product to treat",
    "bbox": [
      108.0,
      545.4,
      527.1,
      558.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b029",
    "text": "bovine respiratory disease or foot rot, and (b) restricting this drug to use by or on the",
    "bbox": [
      108.0,
      558.4,
      518.0,
      571.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b030",
    "text": "order of a licensed veterinarian should help prevent indiscriminate use which could result",
    "bbox": [
      108.0,
      571.4,
      541.0,
      584.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b031",
    "text": "in violative tissue residues.",
    "bbox": [
      108.0,
      584.4,
      241.3,
      597.7
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b032",
    "text": "In accordance with 21 CFR 514.106(b)(2) this is a Category II change which did not",
    "bbox": [
      108.0,
      608.3,
      517.1,
      621.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b033",
    "text": "require a reevaluation of safety and effectiveness data in the parent application.",
    "bbox": [
      108.0,
      622.3,
      492.1,
      635.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b034",
    "text": "This approval does not qualify for marketing exclusivity under section 512(c)(2)(F)(iii)",
    "bbox": [
      108.0,
      646.3,
      531.0,
      659.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b035",
    "text": "of the Federal Food, Drug, and Cosmetic Act.",
    "bbox": [
      108.0,
      660.3,
      331.1,
      673.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 6,
    "block_id": "980_p6_b036",
    "text": "No patent information was submitted with this application.",
    "bbox": [
      108.0,
      684.3,
      393.9,
      697.6
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 7,
    "block_id": "980_p7_b001",
    "text": "7. ATTACHMENTS:",
    "bbox": [
      90.0,
      72.6,
      199.7,
      85.9
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPS-BoldItalicMT",
    "label": "HH3"
  },
  {
    "pdf_id": "980",
    "page_number": 7,
    "block_id": "980_p7_b002",
    "text": "Facsimile labeling is attached as indicated below.",
    "bbox": [
      108.0,
      98.5,
      349.0,
      111.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 7,
    "block_id": "980_p7_b003",
    "text": "A. NAXCEL Sterile Powder - 1 g vial and shipper carton label",
    "bbox": [
      108.0,
      122.5,
      415.9,
      135.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 7,
    "block_id": "980_p7_b004",
    "text": "B. NAXCEL Sterile Powder - 4 g vial and shipper carton label",
    "bbox": [
      108.0,
      136.5,
      415.9,
      149.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  },
  {
    "pdf_id": "980",
    "page_number": 7,
    "block_id": "980_p7_b005",
    "text": "C. NAXCEL Sterile Powder - package insert",
    "bbox": [
      108.0,
      150.5,
      330.8,
      163.8
    ],
    "font_size": 12.0,
    "font_name": "TimesNewRomanPSMT",
    "label": "BODY"
  }
]